Dmitry Pankov

813 total citations
17 papers, 620 citations indexed

About

Dmitry Pankov is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Dmitry Pankov has authored 17 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Dmitry Pankov's work include CAR-T cell therapy research (11 papers), Renal and related cancers (6 papers) and Immunotherapy and Immune Responses (4 papers). Dmitry Pankov is often cited by papers focused on CAR-T cell therapy research (11 papers), Renal and related cancers (6 papers) and Immunotherapy and Immune Responses (4 papers). Dmitry Pankov collaborates with scholars based in United States, Germany and United Kingdom. Dmitry Pankov's co-authors include Richard J. O’Reilly, Tao Dao, David A. Scheinberg, Ekaterina Doubrovina, Liu C, Emily Casey, Andrew Scott, Leonid Dubrovsky, Michael Curcio and Tatyana Korontsvit and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Nature Biotechnology.

In The Last Decade

Dmitry Pankov

15 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitry Pankov United States 11 464 344 194 183 73 17 620
Sabine Stienen Germany 13 491 1.1× 307 0.9× 276 1.4× 148 0.8× 46 0.6× 26 639
Tiffany A. Coupet United States 5 323 0.7× 204 0.6× 160 0.8× 128 0.7× 33 0.5× 7 428
Thies Rösner Germany 16 202 0.4× 463 1.3× 309 1.6× 207 1.1× 27 0.4× 30 666
Melanie Märklin Germany 13 295 0.6× 364 1.1× 55 0.3× 229 1.3× 37 0.5× 49 686
Mireya Paulina Velasquez United States 15 589 1.3× 271 0.8× 99 0.5× 218 1.2× 156 2.1× 42 783
Katja Klausz Germany 18 367 0.8× 444 1.3× 382 2.0× 275 1.5× 19 0.3× 49 780
Dirk Hönemann Australia 9 314 0.7× 227 0.7× 54 0.3× 202 1.1× 112 1.5× 13 511
Ivica Fucek Germany 10 418 0.9× 301 0.9× 304 1.6× 176 1.0× 16 0.2× 28 593
Andrea Crocker United States 11 387 0.8× 725 2.1× 124 0.6× 251 1.4× 50 0.7× 19 878
Jan Davidson‐Moncada United States 12 228 0.5× 215 0.6× 45 0.2× 161 0.9× 50 0.7× 49 518

Countries citing papers authored by Dmitry Pankov

Since Specialization
Citations

This map shows the geographic impact of Dmitry Pankov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitry Pankov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitry Pankov more than expected).

Fields of papers citing papers by Dmitry Pankov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitry Pankov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitry Pankov. The network helps show where Dmitry Pankov may publish in the future.

Co-authorship network of co-authors of Dmitry Pankov

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitry Pankov. A scholar is included among the top collaborators of Dmitry Pankov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitry Pankov. Dmitry Pankov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Dalton, Tanner C., Ekaterina Doubrovina, Dmitry Pankov, et al.. (2020). Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy. Blood. 135(21). 1870–1881. 41 indexed citations
3.
Pankov, Dmitry, Ioanna Eleftheriadou, Sara Brett, et al.. (2020). 96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo. SHILAP Revista de lepidopterología. A60.2–A61. 1 indexed citations
4.
Eleftheriadou, Ioanna, Sara Brett, Magdalena Kijewska, et al.. (2019). NY-ESO-1 and LAGE1A: An emerging target for cell therapies in solid tumours. Annals of Oncology. 30. v503–v503. 2 indexed citations
5.
Ahmed, Mahiuddin, Andrés López‐Albaitero, Dmitry Pankov, et al.. (2018). TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. JCI Insight. 3(4). 34 indexed citations
6.
Hoseini, Sayed Shahabuddin, Konstantin Dobrenkov, Dmitry Pankov, Xiaoliang L. Xu, & Nai‐Kong V. Cheung. (2017). Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2. OncoImmunology. 6(6). e1320625–e1320625. 31 indexed citations
7.
Chang, Aaron Y., Ron S. Gejman, Elliott J. Brea, et al.. (2016). Opportunities and challenges for TCR mimic antibodies in cancer therapy. Expert Opinion on Biological Therapy. 16(8). 979–987. 46 indexed citations
8.
Dubrovsky, Leonid, Elliott J. Brea, Dmitry Pankov, et al.. (2016). Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity. OncoImmunology. 5(9). e1211221–e1211221. 4 indexed citations
9.
Dao, Tao, Dmitry Pankov, Andrew Scott, et al.. (2015). Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature Biotechnology. 33(10). 1079–1086. 126 indexed citations
10.
Dubrovsky, Leonid, Tao Dao, Ron S. Gejman, et al.. (2015). T cell receptor mimic antibodies for cancer therapy. OncoImmunology. 5(1). e1049803–e1049803. 36 indexed citations
11.
Veomett, Nicholas, Tao Dao, Hong Liu, et al.. (2014). Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein. Clinical Cancer Research. 20(15). 4036–4046. 41 indexed citations
12.
Shono, Yusuke, Andrea Z. Tuckett, Samedy Ouk, et al.. (2014). A Small-Molecule c-Rel Inhibitor Reduces Alloactivation of T Cells without Compromising Antitumor Activity. Cancer Discovery. 4(5). 578–591. 42 indexed citations
13.
Pankov, Dmitry, et al.. (2014). Optimization of experimental human leukemia models (review). SHILAP Revista de lepidopterología. 1 indexed citations
14.
Dubrovsky, Leonid, Dmitry Pankov, Elliott J. Brea, et al.. (2014). A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias. Blood. 123(21). 3296–3304. 41 indexed citations
15.
Dao, Tao, Su Yan, Nicholas Veomett, et al.. (2013). Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody. Science Translational Medicine. 5(176). 176ra33–176ra33. 136 indexed citations
16.
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Stienen Breakdown of academic impact, for papers by Tiffany A. Coupet Breakdown of academic impact, for papers by Thies Rösner Breakdown of academic impact, for papers by Melanie Märklin Breakdown of academic impact, for papers by Mireya Paulina Velasquez Breakdown of academic impact, for papers by Katja Klausz Breakdown of academic impact, for papers by Dirk Hönemann Breakdown of academic impact, for papers by Ivica Fucek Breakdown of academic impact, for papers by Andrea Crocker Breakdown of academic impact, for papers by Jan Davidson‐Moncada
Rankless by CCL
2026